Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026
NASHVILLE, Tenn., April 15, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health”…
Month: April 2021
Adamis Pharmaceuticals Announces 2020 Financial Results and Business Update
Phase 2/3 clinical trial for Tempol for the prevention of hospitalizations in patients with COVID-19…
Biogen Grows Presence in China with the Approval of TECFIDERA® (dimethyl fumarate) for the Treatment of Relapsing Multiple Sclerosis
TECFIDERA was approved under the National Medical Products Administration priority review process evaluating therapies with…
Praxis Precision Medicines Adds Development Expertise to Board of Directors with Appointment of Jeffrey Chodakewitz, M.D.
CAMBRIDGE, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…
Pacific Biosciences of California, Inc. First Quarter 2021 Financial Results Call
MENLO PARK, Calif., April 15, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:…
Avid Bioservices Announces Completion of Redemption of Series E Convertible Preferred Stock
TUSTIN, Calif., April 15, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (the “company”),…
Collegium to Host Conference Call to Discuss First Quarter 2021 Financial Results and Provide Corporate Update
STOUGHTON, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today…
TG Therapeutics to Host Investor & Analyst Event to Preview Results from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis
Webcast to be held tomorrow, April 16, 2021 at 8:30 AM ET NEW YORK, April…
Infant Bacterial Therapeutics receives additional patent protection in China
Infant Bacterial Therapeutics AB (IBT) today announces that the Chinese patent office has issued a…
Nabriva Commences Exclusive Distribution of SIVEXTRO® (tedizolid phosphate) in the U.S.
– SIVEXTRO now available under Nabriva’s National Drug Code – 100% of SIVEXTRO’s net product…
GigaGen Publishes Research on Company’s Recombinant Hyperimmunes in Nature Biotechnology
Article describes GigaGen’s technology and approach for the production of a new class of drug,…
Virbac: very strong growth in revenue in the first quarter of 2021 at +22.6% at comparable exchange rates and scope (+12.3% at constant rates), driven by very solid performance in all areas
KEY FIGURES Revenue1st quarter 2021 €266.5 million Growth at constant exchange rates and…
GBS, Inc. Receives Approval to Commence Validation Clinical Study for Rapid SARS-CoV-2 Diagnostic Test
NEW YORK, April 15, 2021 (GLOBE NEWSWIRE) — GBS, Inc. (NasdaqGS: GBS), a life sciences…
Biosplice Therapeutics Closes $120 Million in Equity Financing to Advance Its Alternative Splicing Platform
New investors include Eventide, aMoon, SymBiosis II, Sands Capital and Verition Proceeds to support Biosplice’s…
Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020
Sales increase driven by first sales of COVID-19 Antigen Rapid Test in Europe after January…
Zealand Pharma’s Annual General Meeting 2021
Company announcement – No. 22/ 2021 Zealand Pharma’s Annual General Meeting 2021 Copenhagen, April 15,…
GSK and Vir Biotechnology Announce EMA Review of Dual-Action Monoclonal Antibody VIR-7831 for the Early Treatment of COVID-19
GSK and Vir continue discussions with global regulators to make VIR-7831 available to patients with…
XOMA’s Royalty Portfolio Grows with Addition of Three Royalty Assets
EMERYVILLE, Calif., April 15, 2021 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) today announced its…
BioStem Technologies, Inc. Announces Launch of National Sales Force Expansion
Pompano Beach, Fl., April 15, 2021 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC PINK: BSEM)…
Skye Bioscience to Present at Upcoming Investment Conferences in April
San Diego, Calif, April 15, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE”…